Bayer has been going down over 60% since 2015 because of many lawsuits regarding the Round-up debacle for causing cancer and some incidents regarding a blood thinner medication causing fatalities.
Now there are some positive things starting to show for this stock, the lawsuits in the US for the fatalities are bought off.
Speculations are rising that the market, pricing in a 40 bln dollar liability in the Round-up lawsuits is way too high and will be substantially lower after a long drawn out legal process.
The stock bounced of the .786 fib with nice volume, this is the same range where a very solid resistance formed from 2010 till mid 2012 when a s/r flip occured.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。